Soltec Research

Soltec Research was a prominent Australian biotechnology company focused on the research and development of advanced topical drug delivery systems. The company gained international recognition for its proprietary aerosol foam technology, which revolutionized the application of dermatological treatments by providing non-greasy, quick-drying alternatives to traditional ointments and creams. This technology served as the foundation for successful commercial products including Olux and Luxiq, which were licensed to and marketed by Connetics Corporation. Soltec's expertise spanned formulation science, clinical development, and regulatory affairs for topical pharmaceuticals. In 1997, the company was acquired by FH Faulding & Co, and its innovations continue to be a core component of the global dermatology market through subsequent corporate successions.